News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
ESTRO-EANO guideline on target delineation and radiotherapy for grade 2 and 3 diffuse glioma
Nov 1, 2024, 17:10

ESTRO-EANO guideline on target delineation and radiotherapy for grade 2 and 3 diffuse glioma

ESTRO posted on LinkedIn:

“ESTRO-EANO guideline on target delineation and radiotherapy for IDH mutant WHO CNS grade 2 and 3 diffuse glioma, just published in the Green Journal.”

ESTRO-EANO guideline on target delineation and radiotherapy for grade 2 and 3 diffuse glioma

 

cancer ESTRO ESTRO-EANO glioma Green Journal OncoDaily Oncology
Special Coverage
Blog
Mar 30, 2025, 17:05
Julien Mazieres: Heterogeneity of resistance mechanisms should lead to a personalized strategy to overcome resistance
Blog
Mar 30, 2025, 16:56
Joe Chang: Optimal first-line treatment for EGFR-mutated mNSCLC
Positive
Mar 30, 2025, 16:44
Yüksel Ürün: FDA approves neoadjuvant and adjuvant durvalumab in MIBC
Blog
Mar 30, 2025, 16:43
Highlights from SSO25
Blog
Mar 30, 2025, 16:38
Embracing Palliative Care in Paediatric Oncology from Diagnosis Onwards course is now available on YouTube - SIOPE
Blog
Mar 30, 2025, 16:09
Hedley Lewis: No Family Should Face Childhood Cancer and Life-Threatening Blood Disorders Alone
Blog
Mar 30, 2025, 16:06
Anant Madabhushi: New Publication on AI-Driven Virtual Staining for Tumor-Associated Macrophages
Blog
Mar 30, 2025, 16:03
Research drives progress, and advocacy fuels change - Fight Colorectal Cancer
Blog
Mar 30, 2025, 15:52
St. Baldrick's Foundation - Honoring our heroes on National Doctors' Day
Blog
Mar 30, 2025, 15:48
Our experts are in Orlando for NCCN2025 - Roswell Park
Blog
Mar 30, 2025, 15:42
Peter Pisters: Honoring MD Anderson Cancer Center's Physicians on Doctors' Day for their commitment
Blog
Mar 30, 2025, 15:41
New NCI Funding Opportunity to New NCI Funding Opportunity to Address Cancer-Related Financial Hardship to Improve Patient Outcomes